COVID-19 Vaccine-induced Inflammatory Heart Disease Prevalence Registry

Abroad (travel likely)Recruiting

Conditions

Myocarditis · Pericarditis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Ottawa Heart Institute, Ottawa, Ontario, Canada
Contact: Study coordinator (Tahir Kafil, MD) · tkafil@ottawaheart.ca · 6136967327
Contact: Study coordinator (Peter Liu, MD) · pliu@ottawaheart.ca · 6136967351

Study leads

Peter Liu, MD
Principal Investigator
Ottawa Heart Institute Research Corporation

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases

Myocarditis · ANCA Associated Vasculitis · Pericarditis

Abroad (travel likely)Recruiting

Paris, France

ATROPOS: Survival Analysis of ICI-associated Myocarditis

Immune Checkpoint Inhibitor-associated Myocarditis

Abroad (travel likely)Recruiting

Paris, France

BEAT-SHOCK Registry

Cardiogenic Shock · Myocardial Infarction (MI) · Fulminant Myocarditis

Abroad (travel likely)Recruiting

Basel, Switzerland

AI-powered ECG Analysis for Deadly Arrhythmias and ICI Myocarditis

Arrhythmia · Long QT Syndrome · Immune Checkpoint Inhibitor-Related Myocarditis

Abroad (travel likely)Recruiting

Paris, France